07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

257. Alcohol Intake and Preference<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 257.12/Z29<br />

Topic: C.16.a. Alcohol<br />

Support: NIAAA (AA015434)<br />

Integrative <strong>Neuroscience</strong> Initiative on Alcoholism - West<br />

<strong>Title</strong>: Synthetic cannabinoid antagonist SR141716A decreases binge-like alcohol intake in<br />

C57BL/6J mice<br />

Authors: *D. N. LINSENBARDT, C. WALSH, E. MOORE, S. BOEHM, II;<br />

Dept Psychol, Univ. Binghamton, Binghamton, NY<br />

<strong>Abstract</strong>: Research in rodents has suggested a role <strong>for</strong> the CB1 receptor system in modulating<br />

voluntary ethanol intake and preference. Whereas, cannabinoid agonists increase ethanol<br />

consummatory behaviors such as ethanol-maintained responding (Gallate et al., 1999), and 2<br />

bottle choice preference (Colombo et al., 2002), the cannabinoid antagonist SR141716A<br />

effectively blocks these effects. Interestingly, SR141716A has also been shown to decrease<br />

ethanol consummatory behaviors in various strains of mice (Arnone et al., 1997; Hungund et al.,<br />

2002) and rats (Colombo et al., 1998; Freedland et al., 2001). Along these lines, previous<br />

research from our lab has shown that the cannabinoid agonist WIN 55-212,2 is capable of<br />

increasing binge-like intake using a modified version of the „Drinking In the Dark‟ (DID) model.<br />

The goal of the present work was to further examine the extent to which the endocannabinoid<br />

system is involved in binge-like alcohol intake through antagonism of the CB1 receptor system<br />

using SR141716A. C57BL/6J mice were allowed six days of once a day access to DID. On day<br />

7, mice were injected with one of three concentrations of SR141716A or vehicle and binge-like<br />

alcohol intake and corresponding blood alcohol concentrations were recorded. SR141716A dosedependently<br />

decreased alcohol consumption compared to vehicle injected controls. These<br />

findings provide further support <strong>for</strong> the growing literature implicating the endogenous<br />

cannabinoid system in ethanol preference and intake and suggest that this system may mediate<br />

binge-like consumption.<br />

Disclosures: D.N. Linsenbardt , None; C. Walsh, None; E. Moore, None; S. Boehm, None.<br />

Poster<br />

257. Alcohol Intake and Preference

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!